Literature DB >> 18270757

Minimum requirements of hydrophobic and hydrophilic features in cationic peptide antibiotics (CPAs): pharmacophore generation and validation with cationic steroid antibiotics (CSAs).

Sandeep Sundriyal1, Rohit K Sharma, Rahul Jain, Prasad V Bharatam.   

Abstract

Cationic peptide antibiotics (CPAs) are known to possess amphiphilic structure, by virtue of which they display lytic activity against bacterial cell membranes. Naturally occurring antimicrobial peptides contain a large number of amino acid residues, which limits their clinical applicability. Recent studies indicate that it is possible to decrease the chain-length of these peptides without loss of activity, and suggest that a minimum of two positive ionizable (hydrophilic) and two bulky groups (hydrophobic) are required for antimicrobial activity. By employing the HipHop module of the software package CATALYST, we have translated these experimental findings into 3-D pharmacophore models by finding common features among active peptides. Positively ionizable (PI) and hydrophobic (HYD) features are the important characteristics of compounds used for pharmacophore model development. Based on the highest score and the presence of amphiphilic structure, two separate hypothesis, Ec-2 and Sa-6 for Escherichia coli and Staphylococcus aureus, respectively, were selected for mapping analysis of active and inactive peptides against these organisms. The resulting models not only provided information on the minimum requirement of PI and HYD features but also indicated the importance of their relative arrangement in space. The minimum requirement for PI features was two in both cases but the number of HYD features required in the case of E. coli was four while for S. aureus it was found to be three. These hypotheses were able to differentiate between active and inactive CPAs against both organisms and were able to explain the experimental results. The hypotheses were further validated using cationic steroid antibiotics (CSAs), a different class of facial amphiphiles with same mechanism of antimicrobial action as that of CPAs. The results showed that CSAs also require similar minimum features to be active against both E. coli and S. aureus. These studies also indicate that the minimum feature requirements may be conserved for different strains of the same organism. Figure shows the mapping of an active cationic peptide antibiotic (CPA) mapped to the most acceptable hypothesis Sa6 against S. aureus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18270757     DOI: 10.1007/s00894-008-0268-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  34 in total

Review 1.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides.

Authors:  Y Shai
Journal:  Biochim Biophys Acta       Date:  1999-12-15

Review 2.  Host defence (cationic) peptides: what is their future clinical potential?

Authors:  R E Hancock
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

3.  Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa.

Authors:  L Zhang; P Dhillon; H Yan; S Farmer; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 4.  Amphipathic, alpha-helical antimicrobial peptides.

Authors:  A Tossi; L Sandri; A Giangaspero
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

5.  Action of antimicrobial peptides: two-state model.

Authors:  H W Huang
Journal:  Biochemistry       Date:  2000-07-25       Impact factor: 3.162

Review 6.  Host-defense antimicrobial peptides: importance of structure for activity.

Authors:  N Sitaram; R Nagaraj
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

Review 7.  Antibiotics: where did we go wrong?

Authors:  Karen M Overbye; John F Barrett
Journal:  Drug Discov Today       Date:  2005-01-01       Impact factor: 7.851

8.  The challenge of antibiotic resistance.

Authors:  S B Levy
Journal:  Sci Am       Date:  1998-03       Impact factor: 2.142

Review 9.  Cationic peptides: a new source of antibiotics.

Authors:  R E Hancock; R Lehrer
Journal:  Trends Biotechnol       Date:  1998-02       Impact factor: 19.536

Review 10.  Infective endocarditis: a review of the best treatment options.

Authors:  Leonardo Calza; Roberto Manfredi; Francesco Chiodo
Journal:  Expert Opin Pharmacother       Date:  2004-09       Impact factor: 3.889

View more
  2 in total

1.  CYP isoform specificity toward drug metabolism: analysis using common feature hypothesis.

Authors:  M Ramesh; Prasad V Bharatam
Journal:  J Mol Model       Date:  2011-05-12       Impact factor: 1.810

2.  Binaphthyl-anchored antibacterial tripeptide derivatives with hydrophobic C-terminal amino acid variations.

Authors:  John B Bremner; Paul A Keller; Stephen G Pyne; Mark J Robertson; K Sakthivel; Kittiya Somphol; Dean Baylis; Jonathan A Coates; John Deadman; Dharshini Jeevarajah; David I Rhodes
Journal:  Beilstein J Org Chem       Date:  2012-08-09       Impact factor: 2.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.